Nascent Biotech (NBIO) Total Assets by Year
Nascent Biotech closed fiscal year 2024 with $552K in total assets, $809K in total liabilities and -$257K in shareholder equity. This represents an increase of 116.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Nascent Biotech has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NBIO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $552K+116.5% | $255K+141.9% | $105K-86.0% | $751K+23251.0% | $3K-97.6% | $131K+12.4% | $117K-87.0% | $900K-35.8% | $1.4M+49.5% | $938K+715.3% | $115K |
| Total Liabilities | $809K-47.9% | $1.6M+99.7% | $777K-36.5% | $1.2M-57.5% | $2.9M+369.2% | $614K+201.7% | $203K+22.5% | $166K-94.4% | $3.0M-5.5% | $3.1M+100.9% | $1.6M |
| Total Equity | -$257K+80.2% | -$1.3M-93.0% | -$671K-42.1% | -$473K+83.6% | -$2.9M-496.4% | -$482K-458.2% | -$86K-111.8% | $734K+146.8% | -$1.6M+28.9% | -$2.2M-52.2% | -$1.5M |
NBIO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $227K+188.1% | $552K+116.5% | $641K+13.3% | $1.0M-13.2% | $79K-56.9% | $255K+141.9% | $566K-24.7% | $1.2M+1039.2% | $183K-33.5% | $105K-86.0% | $752K+930.0% | $105K+6.3% |
| Total Liabilities | $742K-37.9% | $809K-47.9% | $611K-68.3% | $1.0M-56.1% | $1.2M-26.3% | $1.6M+99.7% | $1.9M+60.9% | $2.4M+107.6% | $1.6M+45.9% | $777K-36.5% | $1.2M-8.1% | $1.2M+26.4% |
| Total Equity | -$515K+53.9% | -$257K+80.2% | $30K+102.2% | -$6K+99.5% | -$1.1M+22.4% | -$1.3M-93.0% | -$1.4M-204.5% | -$1.2M-13.6% | -$1.4M-72.2% | -$671K-42.1% | -$448K+63.6% | -$1.0M-28.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Nascent Biotech financials
Frequently Asked Questions
What was Nascent Biotech's total assets in fiscal year 2024?
Nascent Biotech closed fiscal year 2024 with $552K in total assets, $809K in total liabilities and -$257K in shareholder equity.
How fast is Nascent Biotech's total assets growing?
Nascent Biotech (NBIO) total assets rose by 116.5% year over year, from $255K to $552K in fiscal year 2024.
How has Nascent Biotech's total assets changed over the years?
Across the 11 fiscal years this page covers, Nascent Biotech (NBIO) total assets went from $115K in fiscal year 2014 to $552K in fiscal year 2024.
What was Nascent Biotech's total assets in the most recent quarter?
Nascent Biotech (NBIO) reported $227K in total assets in Q1 2025. This represents an increase of 188.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Nascent Biotech (NBIO) reported on that line in every period on record.